4952 The proportion of subjects withdrawing from trials due to gastrointestinal symptoms is about 5%
According to NICE Technology Appraisal 875 , semaglutide 2.4 mg (Wegovy) may be considered for adults with a BMI of at least 35 kg/m, or at least 30 kg/m with at least one weight-related comorbidity
GLP-1 receptor agonists work by slowing down stomach emptying
Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications
In December 2023, the European Medicines Agencys Pharmacovigilance Risk Assessment Committee announced an update on its review of GLP-1 RAs and suicidal thoughts and thoughts of self-harm, which began in July 2023
(9) G V Budazhabon, B I Kuznik, V G Morozov, N N Orlova, and V Kh Khavinson (1984) [Immunogenesis and hemostasis in patients with exacerbated chronic glomerulonephritis treated with thymalin] Ter Arkh, 1984, Volume 56 (Issue 10), Pages 62-6